ARCHIVES

In Brief: ACS Begins Narrowing List of Job Applicants; IL-2 Gets BRM Ok; Pitot Resigns McArdle Post

This article is from The Cancer Letter archive.

Vol. 18 No. 05 | January 31, 1992

Download PDF Visit The Full Archive

Related Articles

CCI Will Tackle Reimbursement Issue

May 16, 1980

FDA To Once Again Review ESA Label To Reflect Results Of Negative Studies.

December 7, 2007

Control AC Hear Report On High Risk conference, Messer Survey

September 6, 1974

NCI Spent $381.2 Million On PR From 2006 to 2012, Vastly Outspending Other NIH, FDA Units

March 1, 2013

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

December 27, 2013

Two Groups Form to Mark Cancer Act’s 25th Anniversary

May 31, 1996